Recurrent relapses of depression in a patient established on sertraline after taking herbal medicinal mixtures - A herb-drug interaction?

Journal of Psychopharmacology

Volumn 23, Issue 2, 2009, Pages 216-219

  Prasad, K P R C ^a   Tharangani, P G D ^a   Samaranayake, C N ^a  

^a UNIVERSITY OF RUHUNA   (Sri Lanka)

Author keywords

Commiphora wighteii; Cytochrome P450; Depression; Herb drug interaction; Sertraline; Sri Lanka; SSRI; Terminalia chebula

Indexed keywords

ARTHRITIS QR; BR 16A; CHOLESTEROL QR; COMMIPHORA WIGHTEII EXTRACT; HERBACEOUS AGENT; RUMALAYA; SERTRALINE; TERMINALIA CHEBULA EXTRACT; UNCLASSIFIED DRUG; PLANT EXTRACT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; AYURVEDA; CASE REPORT; COMMIPHORA; COMMIPHORA WIGHTEII; DRUG EFFICACY; FEMALE; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; RELAPSE; CHEMISTRY; DEPRESSION; HERB DRUG INTERACTION; MIDDLE AGED; PHYTOTHERAPY; RECURRENT DISEASE; TERMINALIA;

COMMIPHORA; DEPRESSIVE DISORDER; FEMALE; HERB-DRUG INTERACTIONS; HUMANS; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TERMINALIA;

EID: 67651153077     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089808     Document Type: Article

References (21)

1. Aquil F, Sajjad M, Khan A, Owais M, Ahmad I, (2005) Effect of certain bioactive plant extracts on clinical isolates of beta lactamase producing methicillin resistant Staphyloccus aureus. J Basic Microbiol 45: 106 - 114.
2. Bajpai M, Pande A, Tewari SK, Prakash D, (2005) Phenolic contents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr 56: 287 - 291.
3. Black K, Shea C, Dursun S, Kutcher S, (2000) Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 25: 255 - 261.
4. Brobst DE, Ding X, Creech KL, Goodwin B, Kelley B, Staudinger JF, (2004) Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther 310: 528 - 535.
5. DeVane CL, Liston HL, Markowitz JS, (2002) Clinical pharmacokinetic of sertraline. Clin Pharmacokinet 41: 1247 - 1266.
6. Ernst E, (2002) Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 252: 107 - 113.
7. Fugh-Berman A, (2000) Herb-drug interactions. Lancet 355: 134 - 138.
8. Gelder M, Mayou R, Cowen P, (2001) Shorter Oxford Textbook of Psychiatry, fourth ed. Oxford: Oxford University Press.
9. Gohil KJ, Patel JA, (2007) Herb-drug interactions: a review and study based on assessment of clinical case reports in literature. Indian J Pharmacol 39: 129 - 139.
10. Gunatilaka AAL, Sotheeswaran S, (1980) Economically useful plants of Sri Lanka Part iii: a phytochemical screening of one hundred medicinal plant materials from ayurvedic shops. J Natl Sci Counc Sri Lanka 8: 11 - 29.
11. Hu Z, Yang X, Lui Ho PC, Chan SY, Sia Heng PW, Chan E, (2005) Herb-drug interactions - a literature review. Drugs 65: 1239 - 1282.
12. Khan A, Shad MU, Preskorn SH, (2000) Lack of sertraline efficacy probably due to an interaction with carbamazepine. J Clin Psychiatry 61: 526 - 527.
13. Leiter FL, Nierenberg AA, Sanders KM, Stern TA, (1995) Discontinuation reactions following sertraline. Biol Psychiatry 38: 694 - 695.
14. Markowtiz JS, DeVane CL, (2000) Rifampicin induced selective serotonin re-uptake inhibitor withdrawal syndrome in a patient treated with sertraline. J Clin Psychopharmacol 20: 109 - 110.
15. Rupasinghe L, (2002) Indeginous system of medicine in Sri Lanka. In: RR Chaudhury, UM Rafei, (eds). Traditional Medicine in Asia. New Delhi: WHO.
16. Sahni S, Hepfinger CA, Sauer KA, (2005) Guggulipid use in hyperlipidemia: case report and review of the literature. Am J Health Syst Pharm 62: 1690 - 1692.
17. Snchez C, Hyttel J, (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19: 467 - 489.
18. Scott GN, Elmer GW, (2002) Update on natural product-drug interactions. Am J Health Syst Pharm 15: 339 - 347.
19. Spinella M, (2001) Psychoactive herbal medications. Skeptical Inquirer 25: 43 - 58.
20. WHO (1993) The ICD-10 Classification of Mental and Behavioural Disorders - Diagnostic Criteria for Research. Geneva: WHO.
21. Zhou S, Gao Y, Jiang W, Huang M Xu, Paxton JW, (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35: 35 - 98.